Indo Us Biotech Limited (INDOUS) fundamentals
Indo Us Biotech Limited is a listed company in Agricultural Food & other Products, part of the Fast Moving Consumer Goods sector, listed on the NSE as INDOUS (ISIN INE250Z01010). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Indo Us Biotech Limited does
Indo US Bio-Tech Limited is a specialized agriculture seed company with its own research station, marketing network and seed production bases. The Company operates through the Seed Cultivation, processing and trading segment. It is involved in crop research and development through breeding, production of seeds, processing, packing and marketing of hybrid and open-pollinated varieties of agricultural crops. Its product portfolio includes a diversified variety of agriculture seeds namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, cumin, coriander, and others. It has a distribution network in the states of Gujarat, Maharashtra, Madhya Pradesh, Chhattisgarh, Rajasthan, Punjab and others. It also exports to many countries, namely the United States, New Jersey, Palestine, Cameroon, Kuwait and others.
Valuation and market data
| Last close | ₹78.20 |
|---|---|
| Market capitalisation | ₹157 crore |
| Enterprise value | ₹159 crore |
| P/E (TTM) | 0.00 |
| Price to book | 2.00 |
| Price to sales (TTM) | 1.39 |
| Book value per share | ₹39.19 |
| Dividend yield | 0.00% |
| Sector | Fast Moving Consumer Goods |
| Industry | Agricultural Food & other Products |
| Listed since | Fri Sep 27 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹110 crore | ₹14 crore | ₹13 crore | 0.00 |
| Mar 2025 | ₹104 crore | ₹17 crore | ₹16 crore | 8.12 |
| Mar 2024 | ₹73 crore | ₹9 crore | ₹8 crore | 4.11 |
| Mar 2023 | ₹62 crore | ₹7 crore | ₹7 crore | 7.51 |
| Mar 2022 | ₹50 crore | ₹5 crore | ₹5 crore | 8.56 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 68.3% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 31.7% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.